A comparison between 2 techniques (immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH)) for her-2/neu detection in lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 361s Year: 2003
Evaluation of the EGFR gene expression in the malignant mesothelioma of Korea using fluorescence in situ hybridization Source: Annual Congress 2008 - Inorganic dust exposure and the lung Year: 2008
Differentiation between squamous cell carcinoma (SCC) and adenocarcinoma (AC): Expression of immunohistochemical (IHC) markers in a tissue microarray (TMA) of >1000 NSCLC Source: Annual Congress 2011 - Molecular pathology and functional genomics of lung disease Year: 2011
Prognosis related gene expression profile in early-stage squamous cell carcinoma of the lung (SqCLC) by real-time quantitative PCR (RT-QPCR) Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007
Evaluation by immunohistochemistry of EGF-R expression before and after chemotherapy in non small cell lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005
An immunohistochemistry (IHC) assessemnt of NSCLC cases Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
High-plex immunofluorescence single cell analysis of fibrotic murine lung on tissue microarrays Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020
High-sensitive-detection of VEGF-mRNA in nonsmall-cell lung cancer (NSCLC) metastases of lymphnodes by thyramide amplified in-situ hybridization Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001
Combined simultaneous analysis of the automated cyto-morphology and I-FISH on the same cell, as a novel method to detect a small population of lung cancer cells Source: Eur Respir J 2006; 28: Suppl. 50, 335s Year: 2006
Telomerase expression in lung tumors Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003
Prevalence of ALK translocations in a large cohort of non-small cell cancer patients and quality of hybridization by sampling method. Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017
Quantitative detection of ALK rearrangements using droplet digital PCR (ddPCR) in liquid biopsies of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016
Correlation of p53, EGFR and HER2 expression in the diagnostic biopsies and the corresponding resected tumours in NSCLC Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003
Her-2/neu expression in advanced non small cell lung carcinomas Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
An analysis of EGFR expression and tumour imaging in non-small cell carcinomas of lung Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011
Correlation of P53 and CerbB-2 expression in the diagnostic biopsies and the corresponding resected tumors in non small cell lung caner Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004
Telomerase vs CD34 and MIB1 in non small cell lung cancer Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008
Validation of PNA-LNA PCR clamp assay for detection of EGFR exon 19 and 21 mutations in various types of clinical non-small cell lung cancer specimens Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013
Pathology and immunohistochemistry of lung cancer Source: Eur Respir Mon; 2009: 44: 15–35 Year: 2009
FGFR1 gene aberrations and FGFR1 protein expression in squamous non-small cell lung cancer (Sq-NSCLC). Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021